Description:
Home Page: www.relieftherapeutics.com
0QKQ Technical Analysis
BAtiment F2/F3
Geneva,
1202
Switzerland
Phone:
41 44 723 59 59
Officers
| Name | Title |
|---|---|
| Mr. Jack Weinstein | CFO, Treasurer & Pres of Relief U.S. |
| Mr. Paolo Galfetti | COO & Director |
| Mr. Jeremy Meinen | Chief Accounting Officer & VP of Fin. & Admin. |
| Dr. Nermeen Varawalla DPhil, M.B.A., M.D., MBA, Ph.D. | Chief Medical Officer |
| Mr. Marco Marotta | Chief Bus. Officer |
| Mr. Anthony M. Kim | Sr. VP & Head of U.S. Commercial Operations |
| Mr. Christopher Wick | Sr. Director & Head of U.S. Sales |
| Ms. Drew Cronin-Fine | Exec. Director & Head of U.S. Marketing |
| Dr. Serene Forte M.P.H., Ph.D. | Sr. VP & Head of Genetic Medicine |
| Mr. David McCullough | Sr. Director & Head of U.S. Market Access |
Exchange: LSE
Country: GB
Currency: British Pound (£)
| GIC Sector: | Industrials |
|---|---|
| GIC Group: | Commercial & Professional Services |
| GIC Industry: | Commercial Services & Supplies |
| GIC Sub-Industry: | Environmental & Facilities Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.9423 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 69 |